Human focal cerebral infarctions induce differential lesional interleukin-16 (IL-16) expression confined to infiltrating granulocytes, CD8+ T-lymphocytes and activated microglia/macrophages

Abbott, 2000, Inflammatory mediators and modulation of blood–brain barrier permeability, Cell. Mol. Neurobiol., 20, 131, 10.1023/A:1007074420772 Arima, 1999, Expression of interleukin-16 by human epithelial cells. Inhibition by dexamethasone, Am. J. Respir. Cell. Mol. Biol., 21, 684, 10.1165/ajrcmb.21.6.3671 Akopov, 1996, Dynamics of polymorphonuclear leukocyte accumulation in acute cerebral infarction and their correlation with brain tissue damage, Stroke, 27, 1739, 10.1161/01.STR.27.10.1739 Baier, 1997, Fighting HIV-1 with IL-16, Nature Med., 6, 605, 10.1038/nm0697-605 Barone, 1999, Inflammatory mediators and stroke: new opportunities for novel therapeutics, J. Cereb. Blood Flow Metab., 19, 819, 10.1097/00004647-199908000-00001 Bazan, 1996, Interleukin-16 or not?, Nature, 381, 29, 10.1038/381029a0 Becker, 1998, Inflammation and acute stroke, Curr. Opin. Neurol., 11, 45, 10.1097/00019052-199802000-00008 Becker, 1997, Immunologic tolerance to myelin basic protein decreases stroke size after transient focal cerebral ischemia, Proc. Natl. Acad. Sci. USA, 94, 10873, 10.1073/pnas.94.20.10873 Center, 1995, The lymphocyte chemoattractant factor, J. Lab. Clin. Med., 125, 167 Center, 1997, Interleukin 16, Int. J. Biochem. Cell Biol., 29, 1231, 10.1016/S1357-2725(97)00053-8 Center, 1996, Interleukin 16 and its function as a CD4 ligand, Immunol. Today, 17, 476, 10.1016/0167-5699(96)10052-I Center, 1982, Modulation of lymphocyte migration by human lymphokines. I. Identification and characterization of chemoattractant activity for lymphocytes from mitogen-stimulated mononuclear cells, J. Immunol., 128, 2563, 10.4049/jimmunol.128.6.2563 Chupp, 1998, Tissue and T cell distribution of precursor and mature IL-16, J. Immunol., 161, 3114, 10.4049/jimmunol.161.6.3114 Cruikshank, 1998, Signaling and functional properties of interleukin-16, Int. Rev. Immunol., 16, 523, 10.3109/08830189809043007 Cruikshank, 1995, Early identification of interleukin-16 (lymphocyte chemoattractant factor) and macrophage inflammatory protein 1 alpha (MIP1 alpha) in bronchoalveolar lavage fluid of antigen-challenged asthmatics, Am. J. Respir. Cell. Mol. Biol., 13, 738, 10.1165/ajrcmb.13.6.7576712 Cruikshank, 1994, Molecular and functional analysis of a lymphocyte chemoattractant factor: association of biologic function with CD4 expression, Proc. Natl. Acad. Sci. USA, 91, 5109, 10.1073/pnas.91.11.5109 Cruikshank, 1991, Lymphocyte chemoattractant factor induces CD4-dependent intracytoplasmic signaling in lymphocytes, J. Immunol., 146, 2928, 10.4049/jimmunol.146.9.2928 Cruikshank, 1987, Lymphokine activation of T4+ T lymphocytes and monocytes, J. Immunol., 138, 3817, 10.4049/jimmunol.138.11.3817 David, 1990, Macrophages can modify the nonpermissive nature of the adult mammalian central nervous system, Neuron, 5, 463, 10.1016/0896-6273(90)90085-T DeKeyser, 1999, Clinical trials with neuroprotective drugs in acute ischaemic stroke: are we doing the right thing?, Trends Neurosci., 22, 535, 10.1016/S0166-2236(99)01463-0 DelZoppo, 2000, Inflammation and stroke: putative role for cytokines, adhesion molecules and iNOS in brain response to ischemia, Brain Pathol., 10, 95, 10.1111/j.1750-3639.2000.tb00247.x Dirnagl, 1999, Pathobiology of ischemic stroke: an integrated view, Trends Neurosci., 22, 391, 10.1016/S0166-2236(99)01401-0 Feuerstein, 1998, Cytokines in brain ischemia — the role of TNF alpha, Cell. Mol. Neurobiol., 18, 695, 10.1023/A:1020690004094 Franz, 1998, Interleukin-16, produced by synovial fibroblasts, mediates chemoattraction for CD4+ T lymphocytes in rheumatoid arthritis, Eur. J. Immunol., 28, 2661, 10.1002/(SICI)1521-4141(199809)28:09<2661::AID-IMMU2661>3.0.CO;2-N Goldblum, 1990, Tumor necrosis factor-alpha augments pulmonary arterial transendothelial albumin flux in vitro, Am. J. Physiol., 258, L57 Jander, 1998, Focal ischaemia of the rat brain elicits an unusual inflammatory response: early appearance of CD8+ macrophages/microglia, Eur. J. Neurosci., 10, 680, 10.1046/j.1460-9568.1998.00078.x Kalimo, 1996, Vascular diseases, 315 Kato, 2000, The initiation of the microglial response, Brain Pathol., 10, 137, 10.1111/j.1750-3639.2000.tb00250.x Kazatchkine, 1996, Interleukin 16 (IL-16) IUIS/WHO Standing Committee on Interleukin Designation, J. Immunol. Methods, 196, 103 Keane, 1998, Conservation of structure and function between human and murine IL-16, J. Immunol., 160, 5945, 10.4049/jimmunol.160.12.5945 Kochanek, 1992, Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke, Stroke, 23, 1367, 10.1161/01.STR.23.9.1367 Krautwald, 1998, IL-16 activates the SAPK signaling pathway in CD4+ macrophages, J. Immunol., 160, 5874, 10.4049/jimmunol.160.12.5874 Laberge, 1999, Phenotype of IL-16-producing cells in bronchial mucosa: evidence for the human eosinophil and mast cell as cellular sources of IL-16 in asthma, Int. Arch. Allergy Immunol., 119, 120, 10.1159/000024186 Lee, 1999, The changing landscapes of ischaemic brain injury, Nature, 399, A7, 10.1038/399a007 Lipton, 1999, Ischemic cell death in brain neurons, Physiol. Rev., 79, 1431, 10.1152/physrev.1999.79.4.1431 Liu, 1999, Identification of a CD4 domain required for interleukin-16 binding and lymphocyte activation, J. Biol. Chem., 274, 23387, 10.1074/jbc.274.33.23387 Maciaszek, 1997, IL-16 represses HIV-1 promoter activity, J. Immunol., 158, 5, 10.4049/jimmunol.158.1.5 Mathy, 2000, Cutting edge: CD4 is not required for the functional activity of IL-16, J. Immunol., 164, 4429, 10.4049/jimmunol.164.9.4429 Muhlhahn, 1998, Structure of interleukin 16 resembles a PDZ domain with an occluded peptide binding site, Nature Struct. Biol., 5, 682, 10.1038/1376 Ponting, 1997, PDZ domains: targeting signalling molecules to sub-membranous sites, BioEssays, 19, 469, 10.1002/bies.950190606 Postler, 1997, Expression of the S-100 proteins MRP-8 and -14 in ischemic brain lesions, Glia, 19, 27, 10.1002/(SICI)1098-1136(199701)19:1<27::AID-GLIA3>3.0.CO;2-7 Qi, 1995, Fibrin activation of vascular endothelial cells. Induction of IL-8 expression, J. Immunol., 155, 867, 10.4049/jimmunol.155.2.867 Rapalino, 1999, Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats, Nature Med., 4, 814, 10.1038/nm0798-814 Raivich, 1999, Neuroglial activation repertoire in the injured brain: graded response, molecular mechanisms and cues to physiological function, Brain Res. Rev., 30, 77, 10.1016/S0165-0173(99)00007-7 Ryan, 1995, The CD4-associated tyrosine kinase p56lck is required for lymphocyte chemoattractant factor-induced T lymphocyte migration, J. Biol. Chem., 270, 17081, 10.1074/jbc.270.29.17081 Schluesener, 1996, Leukocyte chemotactic factor, a natural ligand to CD4, is expressed by lymphocytes and microglial cells of the MS plaque, J. Neurosci. Res., 44, 606, 10.1002/(SICI)1097-4547(19960615)44:6<606::AID-JNR11>3.0.CO;2-W Schwab, 2000, Selective accumulation of cyclooxygenase-1-expressing microglial cells/macrophages in lesions of human focal cerebral ischemia, Acta Neuropathol., 99, 609, 10.1007/s004010051170 Sciaky, 2000, Cultured human fibroblasts express constitutive IL-16 mRNA: cytokine induction of active IL-16 protein synthesis through a caspase-3-dependent mechanism, J. Immunol., 164, 3806, 10.4049/jimmunol.164.7.3806 Stoll, 1998, Inflammation and glial responses in ischemic brain lesions, Prog. Neurobiol., 56, 149, 10.1016/S0301-0082(98)00034-3 Streit, 1999, Reactive microgliosis, Prog. Neurobiol., 57, 563, 10.1016/S0301-0082(98)00069-0 Viglianti, 1997, IL-16 anti-HIV-1 therapy, Nature Med., 3, 938, 10.1038/nm0997-938 Yamasaki, 1995, Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats, Stroke, 26, 676, 10.1161/01.STR.26.4.676 Zhang, 1998, Processing and activation of pro-interleukin-16 by caspase-3, J. Biol. Chem., 273, 1144, 10.1074/jbc.273.2.1144 Zhou, 1997, Human CD4+ cells transfected with IL-16 cDNA are resistant to HIV-1 infection: inhibition of mRNA expression, Nature Med., 3, 659, 10.1038/nm0697-659